Christopher Sweeney, MBBS
Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher Sweeney, MBBS as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:47 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT01574937 · XL-184+Abiraterone in Post-Chemo CRPCDana-Farber Cancer Institute · completed · Prostate Cancer · principal investigator
- Ph3NCT00309985 · Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerECOG-ACRIN Cancer Research Group · completed · Metastatic Hormone-sensitive Prostate Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- ECOG-ACRIN Network Group Statistics and Data Management CenterU10CA180794 · NCI · DANA-FARBER CANCER INST · PI PAUL J CATALANO, CONSTANTINE A. GATSONIS · fiscal years 2014 to 2026Named on NCT00309985
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.